Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographs

Health Canada recommends modified wording for the indications and clinical uses of fludeoxyglucose (F-18 FDG) products in their product monographs. The modified wording aims to bring the indications and clinical uses for F-18 FDG up-to-date and harmonize the product monographs in this regard.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Avis aux intervenants : Harmonisation des monographies des produits à base de fluorodésoxyglucose (F-18 FDG)
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2021-01-06 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["harmonisation des monographies de produits", "fludésoxyglucose", "F-18 FDG", "indications-et-utilisations-cliniques", "indications-et-utilisations-cliniques du F-18 FDG"], "en": ["harmonizing product monographs", "fludeoxyglucose", "F-18 FDG", "indications-and-clinical-uses", "indications-and-clinical-uses for F-18 FDG"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source